logo

For the Inventor, By the Inventor

Le Raincy, France

Lucien Nedelec

USPTO Granted Patents = 72

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 395(Granted Patents)

Forward Citations (Not Self Cited) = 363(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • La Raincy, FR (1987 - 1994)
  • Le Rainey, FR (1994)
  • Le Raincy, FR (1976 - 2004)

Company Filing History:

goldMedal69 out of 854 
 
Roussel Uclaf
 patents
silverMedal1 out of 377 
 
Aventis Pharma S.a.
 patents
bronzeMedal2 out of 832,891 
Other
 patents

Years Active: 1976-2004

Loading Chart...
Areas of Expertise:
19-Nor-Steroids
Steroid Esters
Dopaminergic Compounds
Indoles
Cyclopentanophenanthrene
Amino Acid Derivatives
Anxiolytic Agents
Neuroprotective Activity
Pharmaceutical Compositions
Tetrahydropyridinyl-Indoles
Novel Steroids
Spiro Ring Steroids
72 patents (USPTO):Explore Patents
1. 6790971 - 19-Nor-steroids (2004-09-14),
2. 5707982 - 19-nor-steroids (1998-01-13),
3. 5336686 - 17 Methylene lactones of steroids (1994-08-09),
4. 5302719 - N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines (1994-04-12),
5. 5290771 - 19-nor-steroids (1994-03-01),
6. 5276023 - 19-nor-steroid esters (1994-01-04),
7. 5202316 - N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines (1993-04-13),
8. 5189065 - Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an (1993-02-23),
9. 5166146 - Amino acid cyclopentanophenonthrene compounds (1992-11-24),
10. 5149696 - 19.fwdarw.nor.fwdarw.steroids (1992-09-22),
11. 5108996 - 19-nor-3-keto steroids (1992-04-28),
12. 5084450 - Novel steroids (1992-01-28),
13. 5081113 - Novel 3-keto-steroids (1992-01-14),
14. 5006518 - Novel 17.beta.-hydroxy-19-nor-steroids (1991-04-09),
15. 4987128 - Novel 10.beta.-alkynyl-steroids (1991-01-22),

Title: Unveiling the Ingenious Inventor Lucien Nedelec

Introduction:

Lucien Nedelec is a prominent inventor hailing from Le Raincy, France, with an impressive track record of 72 patents to his name. His innovative contributions have significantly impacted the field of pharmaceuticals and chemical compounds, with a particular focus on 19-nor-steroids.

Latest Patents:

Among his latest patents, the 19-Nor-steroids stand out as a groundbreaking development in the pharmaceutical industry. The unique formula and structure of these steroids, as outlined in his patents, demonstrate Lucien Nedelec's mastery of chemical composition and innovation in this specialized field.

Career Highlights:

Throughout his career, Lucien Nedelec has made significant strides in the pharmaceutical sector, showcasing his expertise in developing novel compounds with potential therapeutic benefits. His tenure at reputable companies like Roussel Uclaf reflects his strong background in research and development within the pharmaceutical domain.

Collaborations:

Lucien Nedelec has had the privilege of collaborating with esteemed professionals in the field, including his coworkers Claude Dumont and Daniel Philibert. These collaborative efforts have led to fruitful partnerships and enriched the innovative landscape of pharmaceutical research.

Conclusion:

In conclusion, Lucien Nedelec's pioneering work in the realm of pharmaceutical inventions has solidified his reputation as a visionary inventor. His numerous patents and fruitful collaborations underscore his dedication to pushing the boundaries of scientific discovery, making him a standout figure in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…